Benzinga | Nov 4, 2021 09:46AM EDT

Tarsus Pharmaceuticals, Inc. Presents Data From Two Pioneering Studies On The Prevalence And Impact Of Demodex Blepharitis At The American Academy Of Optometry 2021 Annual Meeting

Titan real-world prevalence study data reveals that Demodex blepharitis accounts for over two-thirds of all blepharitis cases and is highly prevalent in many commonly seen patient groups

New Titan study data analysis showed that current management tools, such as tea tree oil (TTO) and lid wipes, are ineffective at treating Demodex blepharitis

Atlas disease impact study showed that Demodex blepharitis is associated with a significant symptomatic and psychosocial burden, negatively affecting daily life in 80% of patients